Tomohiro Aoki

16PUBLICATIONS
88CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 09, 2026
Targeted therapy in early-stage classical Hodgkin lymphoma.

Tomohiro Aoki, John Kuruvilla

|Mar 03, 2026
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Inna Y Gong, Meenakshi Jeeva, Katrina Hueniken

|Jan 30, 2026
Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Tomohiro Aoki, Gerben Duns, Shinya Rai

|Sep 09, 2025
Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq.

Yifan Yin, Shinya Rai, Aixiang Jiang

|Jun 20, 2025
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.

Shinya Rai, Gerben Duns, Fabian Frontzek

|Dec 19, 2023
Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma.

Tomohiro Aoki, Aixiang Jiang, Alexander Xu

Pageof 3

Frequent Collaborators

7 joint publications

Christian Steidl

5 joint publications

Aixiang Jiang

4 joint publications

Alexander Xu

4 joint publications

David W Scott